Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision

N/AUnknownNCT04904887

Dar Al Shifa Hospital40 enrolled

Overview

phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision

insertion of new intraocular lens enhanced for intermediate vision

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Presbyopia

Interventions

phacoemulsificationPROCEDURE

phacoemulsification with implantation of EYEHANCE IOL

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * normal ocular examination apart from cataract. Exclusion Criteria: * previous ocular surgery. * ocular pathology or corneal abnormalities. * endothelial cell count below 2000 cells/mm2. * corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).

Locations (1)

Daralshifa hospital

Kuwait City, Kuwait

RECRUITING

Outcomes

Primary Outcomes

intermediate vision assessment

Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 80 cm .

Time frame: 6 months postoperatively

near vision assessment

Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 40 cm.

Time frame: 6 months postoperatively

Secondary Outcomes

defocus curve

The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.

Time frame: 6 months postoperatively

Central Contacts

Magda Torky

CONTACT

0096594492487 magda_turkey@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.